Business Kate Sheridan STAT Plus: Prescription apps are gaining ground — and drug makers’ backing — as digital therapeutics
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Conservative group runs ads to defeat Medicare Part B overhaul
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Sanofi threatens to launch a hostile bid for Medivation
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Medivation rejects Sanofi’s $9.3 billion bid as ‘undervalued’
Health Helen Branswell Sanofi science chief says it’s time to ‘think big’ about global epidemics like Zika
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Some investors losing confidence in Valeant, Sanofi abandoning allergy med
Business Karen Weintraub From the ivory tower to the corner office, academics infuse new life into pharma